
YLF-466D
YLF-466D
Catalog No. M33176
YLF-466D (C24) is a novel AMPK activator that inhibits platelet aggregation.
Size | Price / USD | Stock | Quantity |
2MG | 79 | In Stock |
![]() ![]() |
5MG | 121 | In Stock |
![]() ![]() |
10MG | 188 | In Stock |
![]() ![]() |
25MG | 321 | In Stock |
![]() ![]() |
50MG | 459 | In Stock |
![]() ![]() |
100MG | 621 | In Stock |
![]() ![]() |
500MG | 1233 | In Stock |
![]() ![]() |
1G | Get Quote | In Stock |
![]() ![]() |
Biological Information
-
Product NameYLF-466D
-
Brief Description
-
Description
-
Storage
-
NoteResearch use only, not for human use.
-
Reference1. Liu Y, et al. Antiplatelet effect of a newly developed AMP-activated protein kinase activator YLF-466D. Eur J Pharmacol. 2015 Aug 5;760:81-7.?
molnova catalog



related products
-
Cimiracemoside C
Cimiracemoside C is an active component of Cimicifuga racemosa. It activates AMPK and has the potential activity against diabetes.
-
ASP4132
ASP4132 is an orally active AMPK activator (EC50 : 18 nM), has anti-cancer activity.
-
ETC-1002
A small molecule regulator of lipid and carbohydrate metabolism that targets ACC (acetyl-CoA carboxylase) with IC50 of 29 uM.